Patient characteristics
| No | Sex | Age | FEV1(% predicted) | Drugs | Total IgE(kU/l) | Specific IgE(kU/l) | Allergen | Dose (AU) |
|---|---|---|---|---|---|---|---|---|
| BA, inhaled β2 agonist; CR, cromoglycate; DP, dermatophagoides pteronyssinus; F, female; FEV1, forced expiratory volume in the first second; IC, inhaled corticosteroid; IgE, immunoglobulin E; M, male. | ||||||||
| Table 1 displays the sex (male/female) and age (in years) of the patients, the prebronchodilator forced expiratory volume in the first second (FEV1 in % predicted), the drugs taken before the study, serum levels of total (normal range <100 kU/l) and allergen-specific (normal range <0.7 kU/l) immunoglobulin E (IgE) in kilo units (kU/l), and the allergen and the dose (in allergen units, AU) used for segmental allergen challenge. *Dendritic cell counts only from saline and allergen-challenged segments after 24 h. | ||||||||
| 1* | M | 23 | 77 | BA | 548 | 26.1 | Birch | 76 |
| 2 | F | 23 | 92 | BA | 564 | 77.1 | DP | 250 |
| 3 | F | 25 | 94 | BA, IC | 96 | 4.0 | Birch | 30 |
| 4 | F | 25 | 105 | CR, BA | 64 | 16.9 | DP | 18 |
| 5 | F | 23 | 105 | BA | 545 | 12.6 | Rye | 76 |
| 6 | F | 24 | 102 | BA | 155 | 5.2 | Rye | 4 |
| 7 | M | 19 | 114 | BA | 141 | 18.7 | Rye | 600 |